NCT06378398View on ClinicalTrials.gov

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Colorectal Neoplasia
Interventions
DRUG

Omeprazole

Two 20 mg/day omeprazole tablets taken before the first meal each day for 25-45 days.

DRUG

Aspirin

Two 81 mg/day aspirin tablets taken before the first meal each day for 25-45 days.

Trial Locations (2)

43210

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

48109

RECRUITING

The University of Michigan Rogel Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER